NCT04499534View on ClinicalTrials.gov

BRCA1/2 Flu Vaccine

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 28, 2019

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions
BRCA1 MutationBRCA2 Mutation
Interventions
BIOLOGICAL

Seasonal influenza vaccine

To evaluate immune function in BRCA1/2 mutation carriers without cancer following seasonal influenza vaccination

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT04499534 - BRCA1/2 Flu Vaccine | Biotech Hunter | Biotech Hunter